BMJ paediatrics open · 2021
Home phototherapy for neonatal jaundice in the UK: a single-centre retrospective service evaluation and parental survey.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Noureldein Mona, Mupanemunda Grace, McDermott Helen, Pettit Katy, Mupanemunda Richard
Аннотация
BACKGROUND: In the UK setting, where neonatal jaundice treatment is required, it is largely carried out in hospitals. However, it is possible to safely administer home phototherapy (HPT).
OBJECTIVE: To report on our centre's experience of HPT and its potential benefits.
DESIGN: Retrospective observational study performed as a service evaluation.
PATIENTS: Infants ≥35 weeks corrected gestational age with a weight of 2 kg and serum bilirubin ≤50 µmol/L above treatment thresholds. Controls were a matched group of infants who received inpatient phototherapy (IPT).
SETTING: The catchment area of two neonatal intensive care units, one special care unit and a birth centre at four different hospitals that is covered by a single neonatal community outreach nursing team in Birmingham, UK.
INTERVENTION: HPT was started either in the community or as a continuation of IPT. Controls received IPT.
MAIN OUTCOME MEASURES: The rate of bilirubin reduction, hospital readmission rates and parental satisfaction.
RESULTS: 100 infants received HPT while 50 received IPT. No infant showed a progressive rise of serum bilirubin level while receiving HPT. The rate of bilirubin reduction was similar in both HPT and IPT groups (2.4±1.9 and 2.5±1.6 µmol/L/hour, respectively, MD=-0.1, 95% CI -0.74 to 0.53, p=0.74). Readmission rate was 3% in the HPT group. 97% of parents stated that the overall experience was good and 98% would choose HPT if they had their time all over again.
CONCLUSION: Our programme suggests that HPT for neonatal jaundice can be carried out in a select group of infants. It helps in providing holistic family-centred care and is viewed positively by families.
OBJECTIVE: To report on our centre's experience of HPT and its potential benefits.
DESIGN: Retrospective observational study performed as a service evaluation.
PATIENTS: Infants ≥35 weeks corrected gestational age with a weight of 2 kg and serum bilirubin ≤50 µmol/L above treatment thresholds. Controls were a matched group of infants who received inpatient phototherapy (IPT).
SETTING: The catchment area of two neonatal intensive care units, one special care unit and a birth centre at four different hospitals that is covered by a single neonatal community outreach nursing team in Birmingham, UK.
INTERVENTION: HPT was started either in the community or as a continuation of IPT. Controls received IPT.
MAIN OUTCOME MEASURES: The rate of bilirubin reduction, hospital readmission rates and parental satisfaction.
RESULTS: 100 infants received HPT while 50 received IPT. No infant showed a progressive rise of serum bilirubin level while receiving HPT. The rate of bilirubin reduction was similar in both HPT and IPT groups (2.4±1.9 and 2.5±1.6 µmol/L/hour, respectively, MD=-0.1, 95% CI -0.74 to 0.53, p=0.74). Readmission rate was 3% in the HPT group. 97% of parents stated that the overall experience was good and 98% would choose HPT if they had their time all over again.
CONCLUSION: Our programme suggests that HPT for neonatal jaundice can be carried out in a select group of infants. It helps in providing holistic family-centred care and is viewed positively by families.